Characterization of a murine lymphoma cell line by 31P-NMR spectroscopy: In vivo monitoring of the local anti-tumor effects of systemic immune cell transfer

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 484-495

  Fichtner, Klaus Peter ^a   Schirrmacher, Volker ^a   Griesbach, Andreas ^a   Hull, William E ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; PHOSPHODIESTER; PHOSPHOETHANOLAMINE; PHOSPHORUS 31; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; T CELL LYMPHOMA; TUMOR GROWTH;

ANIMALS; ENERGY METABOLISM; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOTHERAPY; LYMPHOMA; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED DBA; NEOPLASMS, EXPERIMENTAL; TIME FACTORS;

EID: 0029950138     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<484::AID-IJC12>3.0.CO;2-8     Document Type: Article

References (33)

1. BENDALL, M.R. and PEGG, D.T., Theoretical description of depth pulse sequences, on and off resonance, including improvements and extensions thereof. Magn. Reson. Med., 2, 91-113 (1985).
2. BENTAL, M. and DEUTSCH, C., Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn. Reson. Med., 29, 317-326 (1993).
3. BRYANT, D.J., BYDDER, G.M., CASE, H.A., COLLINS, A.G., Cox, I.J., MAKEPEACE, A. and PENNOCK, J.M., Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphoma. J. Comput. Assist. Tomogr., 12, 770-774 (1988).
4. 31P MRS of experimental tumours. NMR Biomed., 6, 345-365 (1993).
5. 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Brit. J. Cancer, 63, 953-958 (1991).
6. 14C-radiolabelled compounds in vivo. Biochim. biophys. Acta, 1181, 111-121 (1993).
7. 1H-NMR micro-imaging for monitoring adoptive immunotherapy in a mouse model: detection of metastases and their eradication. Abstracts, Soc. Magn. Reson., 2, 1334 (1994).
8. 31P-MRS of human tumor cells: effects of culture media and conditions on phospholipid metabolite concentrations. Anticancer Res. (1996) (In press).
9. 31P MRS spectra in determining intracellular free magnesium and postassium ion concentrations. Magn. Reson. Med., 33, 467-474 (1995).
10. 31P MS studies of phosphate metabolites and pH in rat tumours. NMR Biomed., 6, 43-52 (1993).
11. KAPLAN, O. and COHEN, J.S., Lymphocyte activation and phospholipid pathways. J. biol. Chem., 266, 3688-3694 (1991).
12. LOWRY, M., PORTER, D.A., TWELVES, C.J., HEASLEY, P.E., SMITH, M.A. and RICHARDS, M.A., Visibility of phospholipids in P-31 NMR spectra of human breast tumours in vivo. NMR Biomed., 5, 37-42 (1992).
13. MELIEF, C.J.M., Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res., 58, 143-175 (1992).
14. MEYERHOFF, D.J., MAUDSLEY, A.A., SCHAEFER, S. and WEINER, M.W., Phosphorus-31 magnetic resonance metabolite imaging in the human body. Magn. Reson. Imaging, 10, 245-256 (1992).
15. 31P-NMR study. Biochim. biophys. Acta, 1093, 29-35 (1991).
16. NEGENDANK, W.G., Studies of human tumors by MRS: a review. NMR Biomed., 5, 303-324 (1992).
17. NEGENDANK, W.G., PADAVIC-SHALLER, K.A., LI, C.-W., MURPHY-BOESCH, J., STOYANOVA, R., KRIGEL, R.L., SCHILDER, R.J., SMITH, M.R. and BROWN, T.R., Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res., 55, 3286-3294 (1995).
18. 31P MRS in situ. Int. J. Radiat. Oncol. Biol. Phys., 13, 1545-1551 (1987).
19. 31P MRS as an early prognostic indicator of patient response to chemotherapy. Magn. Reson. Med., 25, 30-44 (1992).
20. 1H NMR studies of ethanolamine-linked phosphoglycerides metabolism in human T lymphocytes. Cell. mol. Biol., 37, 705-711 (1991).
21. ROSS, B.D., TROPP, J., DERBY, K.A., SUGIURA, S., HAWRYSZKO, C., JACQUES, D.B. and INGRAM, M., Metabolic response of glioblastoma to adoptive immunotherapy: detection by phosphorus MR spectroscopy. J. Comput. Assist. Tomogr., 13, 189-193 (1989).
22. RUIZ-CABELLO, J. and COHEN, J.S., Phospholipid metabolites as indicators of cancer cell function. NMR Biomed., 5, 226-233 (1992).
23. SCHIRRMACHER, V., Immunobiology and immunotherapy of cancer metastases. Ten-year studies in an animal model resulting in the design of an immunotherapy procedure now under clinical testing. Interdisciplinary Science Rev., 14, 291-303 (1989).
24. SCHIRRMACHER, V., BECKHOVE, P., KRÜGER, A., ROCHA, M., UMANSKY, V., FICHTNER, K.-P., HULL, W.E., ZANGEMEISTER-WITTKE, U., GRIESBACH, A., JURIANZ, K. and VON HOEGEN, P., Effective immune rejection of advanced metastasized cancer. Int. J. Oncol., 6, 505-521 (1995).
25. SCHIRRMACHER, V., VON HOEGEN, P., GRIESBACH, A., SCHILD, H.-J. and ZANGEMEISTER-WITTKE, U., Specific eradication of micrometastases by transfer of tumor-immune T cells from major-histocompatibility-complex congenic mice. Cancer Immunol. Immunother., 32, 373-381 (1991).
26. 31P-NMR spectroscopy. NMR Biomed., 6, 254-263 (1993).
27. 31P magnetic resonance spectroscopy. Brit. J. Cancer, 61, 485-490 (1990).
28. 31P magnetic resonance spectroscopy study in non-Hodgkin's lymphoma. Brit. J. Radiol., 64, 923-928 (1991).
29. 31P MRS as a method of measuring pH in rat tumours. NMR Biomed., 5, 351-359 (1992).
30. STUBBS, M., RODRIGUES, L., HOWE, F.A., WANG, J., JEONG, K.-S., VEECH, R.L. and GRIFFITHS, J.R., Metabolic consequences of a reversed pH gradient in rat tumors. Cancer Res., 54, 4011-4016 (1994).
31. 31P magnetic resonance spectroscopy in vivo and in vitro. Brit. J. Cancer, 69, 633-640 (1994).
32. 31P MRS observations of tumour energy metabolism. NMR Biomed., 5, 279-289 (1992).
33. 31P-spectroscopy of head and neck tumors - surface coil technique. Magn. Reson. Imaging, 7, 425-435 (1989).